209 related articles for article (PubMed ID: 10434874)
21. Intraocular cytokine quantification of experimental autoimmune uveoretinitis in rats.
Okada AA; Sakai J; Usui M; Mizuguchi J
Ocul Immunol Inflamm; 1998 Jun; 6(2):111-20. PubMed ID: 9689641
[TBL] [Abstract][Full Text] [Related]
22. The role of lipoprotein-associated phospholipase A2 in a murine model of experimental autoimmune uveoretinitis.
Crawford GL; Boldison J; Copland DA; Adamson P; Gale D; Brandt M; Nicholson LB; Dick AD
PLoS One; 2015; 10(4):e0122093. PubMed ID: 25874928
[TBL] [Abstract][Full Text] [Related]
23. Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats.
Forrester JV; Huitinga I; Lumsden L; Dijkstra CD
Curr Eye Res; 1998 Apr; 17(4):426-37. PubMed ID: 9561835
[TBL] [Abstract][Full Text] [Related]
24. Effect of sex hormones on experimental autoimmune uveoretinitis (EAU).
Buggage RR; Matteson DM; Shen DF; Sun B; Tuaillon N; Chan CC
Immunol Invest; 2003 Nov; 32(4):259-73. PubMed ID: 14603994
[TBL] [Abstract][Full Text] [Related]
25. Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis?
Kreutzer B; Laliotou B; Cheng YF; Liversidge J; Forrester JV; Dick AD
Eye (Lond); 1997; 11 ( Pt 4)():445-52. PubMed ID: 9425406
[TBL] [Abstract][Full Text] [Related]
26. Delayed onset and decreased severity of experimental autoimmune uveoretinitis in mice lacking nitric oxide synthase type 2.
Thillaye-Goldenberg B; Goureau O; Naud MC; de Kozak Y
J Neuroimmunol; 2000 Oct; 110(1-2):31-44. PubMed ID: 11024532
[TBL] [Abstract][Full Text] [Related]
27. [The suppression of the experimental autoimmune uveoretinitis with retinal S antigens by intranasal tolerance induction].
Zheng YZ; Yuan LL; Lin JY; Li HQ
Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1118-22. PubMed ID: 17415971
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
[TBL] [Abstract][Full Text] [Related]
29. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
Zhao J; Chen M; Xu H
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs in retina during development of experimental autoimmune uveoretinitis in rats.
Watanabe T; Keino H; Kudo A; Sato Y; Okada AA
Br J Ophthalmol; 2016 Mar; 100(3):425-31. PubMed ID: 26541434
[TBL] [Abstract][Full Text] [Related]
31. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis.
Dick AD; Cheng YF; Liversidge J; Forrester JV
Immunology; 1994 Aug; 82(4):625-31. PubMed ID: 7835927
[TBL] [Abstract][Full Text] [Related]
32. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietically derived retinal perivascular microglia initiate uveoretinitis in experimental autoimmune uveitis.
Gullapalli VK; Zhang J; Pararajasegaram G; Rao NA
Graefes Arch Clin Exp Ophthalmol; 2000 Apr; 238(4):319-25. PubMed ID: 10853931
[TBL] [Abstract][Full Text] [Related]
34. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
35. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism.
Hoey S; Grabowski PS; Ralston SH; Forrester JV; Liversidge J
J Immunol; 1997 Nov; 159(10):5132-42. PubMed ID: 9366443
[TBL] [Abstract][Full Text] [Related]
37. Cytokines and apoptotic molecules in experimental melanin-protein induced uveitis (EMIU) and experimental autoimmune uveoretinitis (EAU).
Li Q; Sun B; Matteson DM; O'Brien TP; Chan CC
Autoimmunity; 1999; 30(3):171-82. PubMed ID: 10520900
[TBL] [Abstract][Full Text] [Related]
38. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.
Butler TL; McMenamin PG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
40. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
Kwak HJ; Yang YS; Pae HO; Kim YM; Chung HT
Mol Cells; 2001 Oct; 12(2):178-84. PubMed ID: 11710518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
